← Back to Search

Evidence-Based Psychotherapy Training for Cancer-Related Distress

N/A
Recruiting
Led By Jamie Jacobs, Ph.D
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 26 weeks
Awards & highlights

Study Summary

This trial is to train therapists to provide evidence-based psychotherapy tailored to individuals with cancer to help with distress, pain, fatigue, and more. 100 people and 15 therapists will participate over 26 weeks.

Who is the study for?
This trial is for adults over 18 in Massachusetts with cancer-related distress, who are receiving care at MGH Cancer Center. They must report significant distress related to their illness or treatment and be a clinical psychology fellow or psychiatry resident. Excluded are those with uncontrolled psychosis, recent psychiatric hospitalization, cognitive impairments that prevent participation, current psychotherapy involvement, or recent substance dependence.Check my eligibility
What is being tested?
The study trains therapists to provide personalized evidence-based psychotherapies like CBT and ACT to cancer patients experiencing distress. Therapists will choose treatments based on the patient's specific issues such as insomnia or pain. The goal is to see how well these therapies help reduce emotional and physical symptoms caused by cancer.See study design
What are the potential side effects?
Since this trial involves psychological therapy rather than medication, traditional side effects aren't expected. However, participants may experience emotional discomfort when discussing personal issues during therapy sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 26 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 26 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evidence-Based Treatment Acceptability
Secondary outcome measures
Coping Self-Efficacy
Quality of Life (FACT-G)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Training in Individualized Evidence-Based Therapy in Cancer (Therapists)Experimental Treatment1 Intervention
This arm will enroll therapist participants as part of the protocol. Therapists participants will enroll in the study and receive training in delivering evidence-based therapy to patients in the cancer center. Therapists will complete pre and post-measures of therapist self-efficacy and competence, as well as a semi-structured exit interview.
Group II: Individualized Evidence-Based Therapy in Cancer (Patients)Experimental Treatment1 Intervention
This arm will enroll patient participants receiving evidence-based therapy as part of the protocol. Participants will complete: 6-16 sessions of therapy 1x/week. Sessions are virtual or in-person at the Massachusetts General Hospital Cancer Center. Surveys and questionnaires pre- and post-treatment. At the discretion of the therapist and the supervising therapist, the participant may receive up to 4 booster sessions after completion of the specific treatment protocol.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,933 Previous Clinical Trials
13,198,366 Total Patients Enrolled
5 Trials studying Emotional Distress
824 Patients Enrolled for Emotional Distress
Jamie Jacobs, Ph.DPrincipal InvestigatorMassachusetts General Hospital

Media Library

Evidence-Based Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05674357 — N/A
Emotional Distress Research Study Groups: Individualized Evidence-Based Therapy in Cancer (Patients), Training in Individualized Evidence-Based Therapy in Cancer (Therapists)
Emotional Distress Clinical Trial 2023: Evidence-Based Therapy Highlights & Side Effects. Trial Name: NCT05674357 — N/A
Evidence-Based Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05674357 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this study still ongoing?

"The clinicaltrial.gov data shows that this medical trial is not actively enrolling patients at the moment, with its first posting on January 15th 2023 and last update being December 21st 2022. However, there are over 1743 other trials currently accepting participants for their respective studies."

Answered by AI
~77 spots leftby Jan 2028